So far this year, 16 novel drugs have received FDA approval compared to 9 which were greenlighted during the same period last year. Now, let's take a look at the biotech stocks that are awaiting a regulatory decision in May 2020.
from RTT - Biotech https://ift.tt/2KFfxTD
via IFTTT
No comments:
Post a Comment